We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
(+3.5%)
Cap. Flow
-$2.97B
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$77.3M |
| 2 |
Blackstone
BX
|
+$53.2M |
| 3 |
NXP Semiconductors
NXPI
|
+$40.8M |
| 4 |
Palantir
PLTR
|
+$34.3M |
| 5 |
Snowflake
SNOW
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$163M |
| 3 |
Linde
LIN
|
+$133M |
| 4 |
Amazon
AMZN
|
+$94.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$82.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LADR
1976
Ladder Capital
LADR
$1.24B
| $1.88M | ﹤0.01% |
163,088
-7,383
| -4% | -$86.6K |
|
1977
Seres Therapeutics
MCRB
$48.4M
| $1.88M | ﹤0.01% |
3,942
+412
| +12% | +$174K |
|
|
INFN
1978
DELISTED
Infinera Corporation Common Stock
INFN
| $1.88M | ﹤0.01% |
184,131
-47,856
| -21% | -$464K |
|
1979
Metallus
MTUS
$898M
| $1.88M | ﹤0.01% |
132,636
-6,540
| -5% | -$88.4K |
|
1980
Columbus McKinnon
CMCO
$584M
| $1.88M | ﹤0.01% |
38,866
+30
| +0.1% | +$1.54K |
|
|
SHOE
1981
Shoe Station Group
SHOE
$428M
| $1.86M | ﹤0.01% |
52,094
-10,218
| -16% | -$331K |
|
1982
First Busey Corp
BUSE
$2.58B
| $1.86M | ﹤0.01% |
75,572
-12,499
| -14% | -$321K |
|
1983
Middlesex Water
MSEX
$1.1B
| $1.86M | ﹤0.01% |
22,779
+2,889
| +15% | +$239K |
|
|
KNL
1984
DELISTED
Knoll, Inc.
KNL
| $1.86M | ﹤0.01% |
71,658
-11,335
| -14% | -$270K |
|
|
PENG
1985
Penguin Solutions Inc
PENG
$2.99B
| $1.86M | ﹤0.01% |
77,932
-5,684
| -7% | -$137K |
|
|
CSW
1986
CSW Industrials
CSW
$5.71B
| $1.85M | ﹤0.01% |
15,637
-1,250
| -7% | -$159K |
|
1987
Dillards
DDS
$9.56B
| $1.85M | ﹤0.01% |
10,237
-2,731
| -21% | -$352K |
|
1988
Kura Oncology
KURA
$850M
| $1.85M | ﹤0.01% |
88,840
+21,248
| +31% | +$528K |
|
1989
Live Oak Bancshares
LOB
$1.97B
| $1.85M | ﹤0.01% |
31,347
-14,228
| -31% | -$893K |
|
1990
Quanterix
QTRX
$190M
| $1.85M | ﹤0.01% |
31,472
+5,709
| +22% | +$331K |
|
1991
Amphastar Pharmaceuticals
AMPH
$916M
| $1.84M | ﹤0.01% |
91,326
+7,070
| +8% | +$133K |
|
|
CIR
1992
DELISTED
CIRCOR International, Inc
CIR
| $1.84M | ﹤0.01% |
56,440
-11,975
| -18% | -$424K |
|
1993
Hawkins
HWKN
$2.71B
| $1.84M | ﹤0.01% |
56,123
-4,682
| -8% | -$155K |
|
1994
Phibro Animal Health
PAHC
$1.39B
| $1.84M | ﹤0.01% |
63,589
-5,343
| -8% | -$145K |
|
1995
Ameresco
AMRC
$1.36B
| $1.83M | ﹤0.01% |
29,232
+4,680
| +19% | +$252K |
|
1996
Protagonist Therapeutics
PTGX
$9.44B
| $1.83M | ﹤0.01% |
40,812
+7,597
| +23% | +$251K |
|
1997
Conduent
CNDT
$264M
| $1.83M | ﹤0.01% |
243,939
-28,195
| -10% | -$206K |
|
1998
Agilon Health
AGL
$1.6B
| $1.82M | ﹤0.01% |
+1,796
| New | +$1.57M |
|
|
FSP
1999
Franklin Street Properties
FSP
$46.8M
| $1.81M | ﹤0.01% |
344,010
-26,900
| -7% | -$144K |
|
|
TPIC
2000
DELISTED
TPI Composites
TPIC
| $1.8M | ﹤0.01% |
37,269
+2,641
| +8% | +$130K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2021 Portfolio in Review
As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.
- RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
- RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
- RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
- RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
- RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
- RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.
Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.